Skip to search boxSkip to navigationSkip to main content

Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury

  • Bilon Khambu
    ,
  • Tiangang Li
    ,
  • Shengmin Yan
    ,
  • Changshun Yu
    ,
  • Xiaoyun Chen
    ,
  • Michael Goheen
*Corresponding author for this work
  • Indiana University-Purdue University Indianapolis
    ,
  • University of Kansas
    ,
  • Guangzhou Medical College
    ,
  • Icahn School of Medicine at Mount Sinai
    ,
  • Rockefeller University
    ,
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Autophagy is important for hepatic homeostasis, nutrient regeneration, and organelle quality control. We investigated the mechanisms by which liver injury occurred in the absence of autophagy function. We found that mice deficient in autophagy because of the lack of autophagy-related gene 7 or autophagy-related gene 5, key autophagy-related genes, manifested intracellular cholestasis with increased levels of serum bile acids, a higher ratio of tauromuricholic acid/taurocholic acid in the bile, increased hepatic bile acid load, abnormal bile canaliculi, and altered expression of hepatic transporters. In determining the underlying mechanism, we found that autophagy sustained and promoted the basal and up-regulated expression of farnesoid X receptor (Fxr) in the fed and starved conditions, respectively. Consequently, expression of Fxr and its downstream genes, particularly bile salt export pump, and the binding of FXR to the promoter regions of these genes, were suppressed in autophagy-deficient livers. In addition, codeletion of nuclear factor erythroid 2-related factor 2 (Nrf2) in autophagy deficiency status reversed the FXR suppression. Furthermore, the cholestatic injury of autophagy-deficient livers was reversed by enhancement of FXR activity or expression, or by Nrf2 deletion. Conclusion: Together with earlier reports that FXR can suppress autophagy, our findings indicate that autophagy and FXR form a regulatory loop and deficiency of autophagy causes abnormal FXR functionality, leading to the development of intracellular cholestasis and liver injury.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 2196-2213 (18 pages)

Journal (Volume, Issue Number)

Hepatology (Volume 69, Issue 5)

Publication milestones

  • Published - 05/2019

Publication status

Published - 05/2019

ISSN

0270-9139

Publication IDs

  • Scopus: 85062725491
  • PubMed: 30520052

Publication metrics

Metrics

SciVal
FWCI
1.91
SciVal
Author count
15
SciVal
citations
18
SciVal
Paper percentile
95
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.07
Fractional count
14
Fractional count
0.93
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
31
Citation count
49

Funding Details

We thank Dr. Bruno Stieger (University Hospital Zurich, Zurich, Switzerland) for the anti-BSEP and MRP2 antibodies, and Dr. Sabine Werner (Swiss Federal Institute of Technology, Zurich, Switzerland) for the Ca-Nrf2 liver samples. The CK19 and ZO-1 monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD, NIH, and maintained at the Department of Biology, the University of Iowa, Iowa City, IA). We are grateful to Dr. Grace L. Guo (Rutgers University, New Jersey, NJ) for advice on ChIP assay.
FundersFunding number
Swiss Federal Institute of Technology
-
NIH
-
NIAAA
R21AA021450
City
-
UI
-
NICHD
-